A human (immunodeficiency virus) may undergo concentrations.
Inhibitors may reduce concentrations of a human (immunodeficiency virus).
Research can be relevant to preventing a spread of a human (immunodeficiency virus).
A basic science may pertain-to a human (immunodeficiency virus).
Gains can be in understanding a basic science of a human (immunodeficiency virus).
Persons can be with levels of human (immunodeficiency virus).
New generation of drugs may inhibit a human (immunodeficiency virus).
A new generation of drugs may inhibit a human (immunodeficiency virus).
Cases of acquired (immunodeficiency syndrome) may occur in a continent.
Women may have a risk of transmitting a human (immunodeficiency virus).